BD Appoints Robert Huffines and Jacqueline Wright to Board of Directors

Core Insights - BD (Becton, Dickinson and Company) has appointed Robert Huffines and Jacqueline Wright to its board of directors, effective December 1, 2025, enhancing the board's expertise in healthcare, technology, digital transformation, and finance [1][2][5]. Group 1: Board Appointments - Robert Huffines brings over 30 years of experience in healthcare strategy, mergers and acquisitions, and financing, previously serving as global chairman of investment banking at J.P. Morgan [2][3]. - Jacqueline Wright has more than 30 years of experience in technology and digital transformation, having served as the first chief technology and platform officer at McKinsey & Company and held various roles at Microsoft [5][6]. - The addition of these directors reflects BD's commitment to strong corporate governance and regular board refreshment, with three new independent directors added in 2025 [1]. Group 2: Company Strategy and Vision - The appointments are aimed at advancing BD's strategy as a scaled pure-play innovative medical technology company, focusing on unlocking value for shareholders and improving patient care [1][5]. - Both Huffines and Wright expressed their eagerness to support BD in shaping the future of medical technology and enhancing healthcare delivery globally [1][5].